Literature DB >> 17405926

Immunohistochemical evidence for impaired neuregulin-1 signaling in the prefrontal cortex in schizophrenia and in unipolar depression.

Iris Bertram1, Hans-Gert Bernstein, Uwe Lendeckel, Alicja Bukowska, Henrik Dobrowolny, Gerburg Keilhoff, Dimitrios Kanakis, Christian Mawrin, Hendrik Bielau, Peter Falkai, Bernhard Bogerts.   

Abstract

In the central nervous system (CNS), neuregulin-1 (NRG-1) proteins function in neuronal migration, differentiation, and survival of oligodendrocytes. The NRG-1 gene codes for at least 15 different isoforms, which may be classified on the basis of their molecular structure. At least two different haplotypes of the NRG-1 gene may be associated with schizophrenia. An abnormal expression pattern of NRG-1 mRNA was found in the prefrontal cortex of schizophrenic patients in comparison to controls. We here show that the NRG-1alpha isoform is significantly reduced in white matter of the prefrontal cortex in schizophrenia but not in affective disorder. In the prefrontal gray matter, the density of NRG-1alpha expressing neurons was reduced in individuals with schizophrenia and in unipolar patients. We studied brains of 22 schizophrenics, 12 patients with affective disorders (7 unipolar and 5 bipolar), and 22 matched controls. NRG-1alpha immunoreactive material was detected with a polyclonal antiserum against the synthetic peptide from alpha-type EGF-like domain of human NRG. The demonstrated decreased number of NRG-1 immunoreactive neurons in the brains of schizophrenics and patients with unipolar depression points to an important role of this NRG-1alpha splice variant in neuropsychiatric disorders. Reduced NRG-1alpha protein concentrations were found in brains of schizophrenics after Western blot analysis. The diminished expression of NRG-1alpha strongly supports an early neurodevelopmental component to schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17405926     DOI: 10.1196/annals.1397.080

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  43 in total

1.  Increased density of DISC1-immunoreactive oligodendroglial cells in fronto-parietal white matter of patients with paranoid schizophrenia.

Authors:  Hans-Gert Bernstein; Esther Jauch; Henrik Dobrowolny; Christian Mawrin; Johann Steiner; Bernhard Bogerts
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-08-28       Impact factor: 5.270

Review 2.  Early history of subplate and interstitial neurons: from Theodor Meynert (1867) to the discovery of the subplate zone (1974).

Authors:  Miloš Judaš; Goran Sedmak; Mihovil Pletikos
Journal:  J Anat       Date:  2010-10       Impact factor: 2.610

3.  Partial genetic deletion of neuregulin 1 modulates the effects of stress on sensorimotor gating, dendritic morphology, and HPA axis activity in adolescent mice.

Authors:  Tariq W Chohan; Aurelie A Boucher; Jarrah R Spencer; Mustafa S Kassem; Areeg A Hamdi; Tim Karl; Sandra Y Fok; Maxwell R Bennett; Jonathon C Arnold
Journal:  Schizophr Bull       Date:  2014-01-17       Impact factor: 9.306

Review 4.  Neuregulin-1 signalling and antipsychotic treatment: potential therapeutic targets in a schizophrenia candidate signalling pathway.

Authors:  Chao Deng; Bo Pan; Martin Engel; Xu-Feng Huang
Journal:  Psychopharmacology (Berl)       Date:  2013-02-07       Impact factor: 4.530

5.  In human brain ornithine transcarbamylase (OTC) immunoreactivity is strongly expressed in a small number of nitrergic neurons.

Authors:  Hans-Gert Bernstein; Hendrik Dobrowolny; Gerburg Keilhoff; Johann Steiner
Journal:  Metab Brain Dis       Date:  2017-09-03       Impact factor: 3.584

6.  Neuregulin-1 impairs the long-term depression of hippocampal inhibitory synapses by facilitating the degradation of endocannabinoid 2-AG.

Authors:  Huizhi Du; In-Kiu Kwon; Jimok Kim
Journal:  J Neurosci       Date:  2013-09-18       Impact factor: 6.167

7.  Neuregulin 1 genetic variation and anterior cingulum integrity in patients with schizophrenia and healthy controls.

Authors:  Fei Wang; Tianzi Jiang; Zhiguo Sun; Siew-Leng Teng; Xingguang Luo; Zhongjun Zhu; Yufeng Zang; Handi Zhang; Weihua Yue; Mei Qu; Tianlan Lu; Nan Hong; Haiyan Huang; Hilary P Blumberg; Dai Zhang
Journal:  J Psychiatry Neurosci       Date:  2009-05       Impact factor: 6.186

Review 8.  Impact of neuregulin-1 on the pathophysiology of schizophrenia in human post-mortem studies.

Authors:  Andrea Schmitt; Eleni Parlapani; Oliver Gruber; Thomas Wobrock; Peter Falkai
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-11       Impact factor: 5.270

9.  Reversal of behavioral deficits and synaptic dysfunction in mice overexpressing neuregulin 1.

Authors:  Dong-Min Yin; Yong-Jun Chen; Yi-Sheng Lu; Jonathan C Bean; Anupama Sathyamurthy; Chengyong Shen; Xihui Liu; Thiri W Lin; Clifford A Smith; Wen-Cheng Xiong; Lin Mei
Journal:  Neuron       Date:  2013-05-22       Impact factor: 17.173

Review 10.  Neuregulin-ERBB signaling in the nervous system and neuropsychiatric diseases.

Authors:  Lin Mei; Klaus-Armin Nave
Journal:  Neuron       Date:  2014-07-02       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.